The usual dose of 350.mg is unlikely to engender prominent unwanted side effects aside from somnolence, and mild to significant euphoria or dysphoria, nevertheless the euphoria is normally short-lived due to the fast metabolism of carisoprodol into meprobamate and also other metabolites; the euphoria derived is, as outlined by new research, almost certainly because of carisoprodol’s inherent, potent anxiolytic effects which can be far stronger compared to those manufactured by its primary metabolite, meprobamate, and this can be misblamed for the drug-seeking connected with carisoprodol, as carisoprodol itself is responsible to the a lot more intense CNS effects than meprobamate alone.